Lack of a distinctive behavioural effect of chromogranin-derived peptides in rodents (Q43850978)

27 November 2017

Lack of a distinctive behavioural effect of chromogranin-derived peptides in rodents (English)

1 reference

27 November 2017

Gudrun Wakonigg

1

1 reference

27 November 2017

Gerald Zernig

2

1 reference

27 November 2017

Iris Berger

3

1 reference

27 November 2017

Reiner Fischer-Colbrie

4

1 reference

27 November 2017

Andrea Laslop

5

1 reference

27 November 2017

Alois Saria

6

1 reference

27 November 2017

1 February 2002

1 reference

27 November 2017

1 reference

27 November 2017

103

1 reference

27 November 2017

2-3

1 reference

27 November 2017

85-91

1 reference

Formation and sequence analysis of secretoneurin, a neuropeptide derived from secretogranin II, in mammalian, bird, reptile, amphibian and fish brains.

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Secretogranin II: molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Peptides derived from the granins (chromogranins/secretogranins).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

The chromogranins A and B: the first 25 years and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Chromogranin A: localization and stoichiometry in large dense core catecholamine storage vesicles from sympathetic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Biochemistry of the chromogranin A protein family

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Pig splenic nerve: peptides derived from chromogranins by proteolytic processing during axonal transport

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Secretoneurin--a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Attraction of human monocytes by the neuropeptide secretoneurin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Secretoneurin releases dopamine from rat striatal slices: a biological effect of a peptide derived from secretogranin II (chromogranin C).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Sustained dopamine release induced by secretoneurin in the striatum of the rat: a microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Pancreastatin and islet hormone release

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Distribution of secretoneurin-like immunoreactivity in comparison with substance P- and enkephalin-like immunoreactivities in various human forebrain regions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Large variations in the proteolytic formation of a chromogranin A-derived peptide (GE-25) in neuroendocrine tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5-HT1B receptor antagonist activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Secretoneurin-like immunoreactivity in rat sympathetic, enteric and sensory ganglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Evidence for a high density of secretoneurin-like immunoreactivity in the extended amygdala of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Secretoneurin: a market in rat hippocampal pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Neurochemical compartments in the human forebrain: evidence for a high density of secretoneurin-like immunoreactivity in the extended amygdala.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Distribution of secretoneurin-like immunoreactivity in comparison with that of substance P in the human brain stem

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Effects of secretogranin II-derived peptides on the release of neurotransmitters monitored in the basal ganglia of the rat with in vivo microdialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Chromogranin A applied to the nucleus accumbens decreases locomotor activity induced by activation of the mesolimbic dopaminergic system in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Presence and distribution of a new neuropeptide, secretoneurin, in human retina

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

The role of reward pathways in the development of drug dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Molecular characterization of immunoreactivities of peptides derived from chromogranin A (GE-25) and from secretogranin II (secretoneurin) in human and bovine cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

Effects of intracerebroventricular administration of pituitary adenylate cyclase-activating polypeptide (PACAP) on the motor activity and reserpine-induced hypothermia in murines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-0115%2801%2900365-2

7 January 2021

10.1016/S0167-0115(01)00365-2

Identifiers

DOI

1 reference

release_ygyaahrbevfc3cid364sujzviq

27 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ygyaahrbevfc3cid364sujzviq

24 November 2022

mapped directly with Wikidata item

1 reference